Overlæge, dr.med. Kim Dalhoff Giftlinjen & Klinisk Farmakologisk Afd Bispebjerg Hospital Netværk for Forebyggelse af Medicineringsfejl – 10.11.2010 Oplæg.

Slides:

Advertisements

Similar presentations

Aug 7 09 Co-Occurring Service Array Psychiatric Evaluation Comprehensive Evaluation Medication Monitoring Medications Clinical Consultation Family Therapy.

Advertisements

Arianna Ahiagbe ‘12 Human Biology, Sc.B. Thesis Adviser: Bruce Becker, MD, MPH Second Reader: John Marshall, Ph.D. ADHD, INJURY, AND MEDICATION ADHERENCE.

Stimulant Prescribing Training Guide Completion of a ‘Notification of Treatment using Stimulant Medication’ form.

DUR Board Meeting March 12, 2008 West Virginia Department of Health and Human Resources Bureau for Medical Services Drug Utilization Review Board.

QI Initiatives for Psychotropic Use in Foster Youth in Maine Lindsey Tweed MD MPH Office of Child & Family Services; Maine DHHS

University Hospital “Sisters of Charity” Psychiatric Clinic Vinogradska c. 29, 1000 Zagreb, Croatia Davor Moravek Addiction and psychotic.

Relative toxicity of traditional versus atypical antipsychotics in deliberate self poisoning M A Downes, G K Isbister, D Sibbritt, I M Whyte, A H Dawson.

Bipolar Disorder- Assessment B. Anthony Lindsey, MD Professor and Vice Chair UNC Department of Psychiatry.

Trends in Detection Rates of Risky Marijuana Use in CO Healthcare Settings.

Prevalence of Predictors of Antidepressant Prescribing in Nursing Home Residents in the United States Swapna U. Karkare, MS, Sandipan Bhattacharjee, MS,

Addiction Treatment Works! Through Collaboration and Problem Solving amongst all disciplines.

Samantha Martinez Period 3.

NUMBER OF MENTALLY DISORDERED PERSONS ( POPULATION) Data of State Mental Health Centre of Lithuania.

An Educational Perspective Based on Information Contained In The Indiana Prevention Resource Center Factline on Benzodiazepines ®

Adverse Event Tracking as mandated by the Best Pharmaceuticals for Children Act Dr. Solomon Iyasu Medical Team Leader Division of Pediatric Drug Development.

Use of 12 weekly doses of isoniazid and rifapentine for the treatment of latent tuberculosis − Connecticut , Kelley Bemis, MPH CDC/CSTE Applied.

Pharmacological Management. Only symptomatic treatment, there is no cure. Acetylcholinesterase inhibitors - Only for mild to moderate dementia –Donepezil.

DEPRESSION Dr.Jwaher A.Al-nouh Dr.Eman Abahussain

Power B, McQuoid P, Caldwell NA, Clareburt A. Pharmacy Department, Wirral Hospital NHS Trust, Wirral. Poster Layout & Design By Wirral Medical Illustration.

Pharmacist Assisted Management of Complex Psychiatric Patients in Primary Care Casey Gallimore, PharmD, Assistant Professor of Pharmacy Ken Kushner, M.A.,

Collecting data in clinic.  Aim of BADBIR  Definition of Adverse Events  Adverse events in BADBIR  Adverse event recording in hospital case notes.

Toxicology for Medical Students

Early Detection and Treatment of Mental Health and Substance Use/Misuse Issues in Primary Health Primary Care Resources for Helping Patients with Mental.

RELATIVE TOXICITY OF CITALOPRAM AND OTHER SSRIs IN OVERDOSE GK Isbister 1,2, IM Whyte 1,2, AH Dawson 1,2 1 Department of Clinical Toxicology, Newcastle.

Opioid Use: What are the technological, clinical, ethical, and regulatory issues? Michael Von Korff Group Health Research Institute.

Interferences between depression and life quality on patients suffering of type 2 diabetes First Author : Madalina Crisan Coauthors: Madalina Salagean.

Mental Disorders Mental Disorder- Is an illness that affects the mind and reduces person’s ability to function, adjust to change, or get along with others.

A-MOP: An Antipsychotic Medication Optimization Program for Long Term Care Fiona Sudbury, RN, Director of Care Duncan Robertson, Chief of Medical Staff.

Lyn Billington June 2006 Treatment of Attention Deficit/Hyperactivity Disorder Lyn Billington Deputy Pharmacy Manager Latrobe Regional Hospital.

An integrated approach to addressing opiate abuse in Maine Debra L. Brucker, MPA, PhD State of Maine Office of Substance Abuse October 2009.

1 Anti-psychotic Medication in Children, Adolescents and Foster Care: Too Many, too Much, and too Young Medicaid Medical Directors Learning Network (MMDLN)

Finnish prison suicides from 1st January 2001 to 31st December 2010.

DRUGS OF ABUSE Reynaldo J. Lesaca, M.D. Reynaldo J. Lesaca, M.D.

DVT Prevention and Anticoagulant Management

High Risk Medications Narcotics and Sedatives Alex Kardos R.Ph. Director of Pharmacy Services Robert Wood Johnson University Hospital Hamilton.

CRITICAL APPRAISAL OF ARTICLE ON HARM. Among patients with acute rheumatic fever, will administration of non steroidal anti- inflammatory drugs have adverse.

LENGTH OF FIRST HOSPITALIZATION AND OTHER PREDICTORS FOR RE-HOSPITALIZATION IN PSYCHOSES Jouko Miettunen, PhD Department of Psychiatry University of Oulu,

Use of drugs for ADHD in the Nordic countries: The programmer’s perspective! Anton Pottegård Research fellow Clinical Pharmacology University of Southern.

PHARMACOEPIDEMIOLOGICAL MONITORING HELPS IN REDUCING OF NEUROLEPTIC- INDUCED EXTRAPYRAMIDAL DISORDERS AT THE PSYCHIATRIC CLINICAL HOSPITAL OF THE REPUBLIC.

LEADING RESEARCH… MEASURES THAT COUNT Challenges of Studying Cardiovascular Outcomes in ADHD Elizabeth B. Andrews, MPH, PhD, VP, Pharmacoepidemiology and.

SCHOOL OF NURSING UNIVERSITY OF CALIFORNIA, SAN FRANCISCO Not Ready for Prime Time? A Web-Based SBIRT Intervention in an Urban Safety-Net HIV Clinic Carol.

To evaluate the availability of medication studies enrolling patients that are 80 years of age and older. Evaluation of Medication Studies Enrolling Patients.

Table 1. Prediction model for maximum daily dose of buprenorphine-naloxone in a 12-week treatment condition Baseline Predictors Maximum Daily Dose Standardized.

Use of Antipsychotic Drugs in Dementia Josepha A. Cheong, MD University of Florida Departments of Psychiatry and Neurology Chief, Division of Geriatric.

1 Is the ACT model effective in a contemporary Danish psychiatric setting? Preliminary Results from a Danish Multi-centre Trial of Assertive Community.

Anne Mette Dons, MD Head of Department Supervision and Patient Safety

Prilosec1 ® 20 mg Tablets Rx to OTC Switch Daiva Shetty, M.D. Division of Over-the-Counter Drug Products (HFD-560) Food and Drug Administration 1.

بسم الله الرحمن الرحيم Dr: Samah Gaafar Hassan Al-shaygi.

Brain diseases: Substance abuse and co-occurring disorders Mark Publicker, MD FASAM.

An Analysis of Age and Gender Influences on the Relative Risk for Suicide & Psychotropic Drug Self- Poisoning AH Dawson 1, NA Buckley 2, IM Whyte 1, P.

Applying New Science to Drug Safety Janet Woodcock, M.D. Acting Deputy Commissioner for Operations April 15, 2005.

What the National Institute on Drug Abuse’s Clinical Trials Network Can Do for You? Major Findings from Medication Trials and Implications for Community-Based.

Schizoaffective, Delusional and Other Psychotic Disorders Chapter 17.

Zelnorm ® (tegaserod) Division of Gastrointestinal and Coagulation Drug Products Division of Drug Risk Evaluation Gary Della’Zanna, D.O., M.Sc., F.A.C.O.S.

A SIMPLE METHOD FOR ASSESSING IRRATIONAL PRESCRIBING AND PRIORITIZING PRESCRIBING PROBLEMS FOR INTERVENTION: A PILOT STUDY IN UGANDA Hansen EH, Trap B.

STIMLUANTS FOR ADHD Part I Stephen Soltys MD Professor and Chair SIU Department of Psychiatry Double click speaker on subsequent slides.

Dr. Rupak Sethuraman. SPECIFIC LEARNING OBJECTIVES Various management techniques of orofacial pain Management of common orofacial pain disorders.

Efavirenz Use Not Associated With Depressive Episodes, According to Analysis of Randomized Clinical Trial Outcomes Slideset on: Journot V, Chene G, De.

December 10, 2015 Arthur Robin Williams MD MBE American Academy of Addiction Psychiatry Division on Substance Abuse Department of Psychiatry, Columbia.

Konrad Rokita 1, 3, Grzegorz Cessak 1,2, Ewa Bałkowiec-Iskra 1,2,3 1 Department of Experimental and Clinical Pharmacology, Medical University of Warsaw.

Seizure Incidence Associated with Bupropion Dosing Errors Reported to a Local Poison Center William Eggleston, PharmD 1 and Ross W. Sullivan, MD 1,2 1.

USING MEDICINES SAFELY how carers can help

Withdrawal success rating Dosing schedule during withdrawal

POLYPHARMACY IN GERIATRIC PATIENTS Dr SHREYAS MISTRY MD, Dr MAYUR RALI MD HOFSTRA-North Shore LIJ School of Medicine Department of Family Medicine Southside.

A case of the Codeine phosphate abuser, since the seven years

Patterns of asthma medications prescriptions among adult patients in the chest and accident and emergency units of a tertiary health care facility in Uganda.

The European Experience: Prescription Drug Misuse in France, Germany, Italy and Spain 24 October 2017 Presented at Lisbon Addictions 2017 Jody L. Green,

Drug-induced dyskinesias

Treatment-Resistant Schizophrenia

Copyright Notice This presentation is copyrighted by the Psychopharmacology Institute. Subscribers can download it and use it for professional use. The.

Presentation transcript:

Overlæge, dr.med. Kim Dalhoff Giftlinjen & Klinisk Farmakologisk Afd Bispebjerg Hospital Netværk for Forebyggelse af Medicineringsfejl – Oplæg om … Forgiftninger pga. medicineringsfejl Methylphenidat

Overlæge, dr.med. Kim Dalhoff Giftlinjen & Klinisk Farmakologisk Afd Bispebjerg Hospital Medication errors – experience from the Danish Poison Information Service Netværk for Forebyggelse af Medicineringsfejl –

Medication Errors – Tools

53 cases in all Medication Errors – Results

Medication Errors – Results (adjusted for total enquiries per months)

25/53 (47%) Medication Errors – Results

Medication Errors – Results (age groups)

Medication Errors – Results (no of drugs involved)

Medication Errors – Results (no of drugs involved – single dose or multiple doses)

Medication Errors – Results (cause)

Medication Errors – Results (where did the ME take place?)

Medication Errors – Results (symptoms)

Medication Errors – Results (risk assessment!)

Medication Errors – Results (risk assessment - life threatening) 68-year old male (fejldosering) 25 mg haloperidol 100 mg topiramat 300 mg clozapin 2 mg clonazepam 8 mg biperiden 88-year old female (fejldosering) 200 mg labetalol 83-year old male (beh krævende, forveksling)  60 mg diltiazem 125 mg levodopa 20 mg citalopram 100 mg mandolgin

Medication Errors – Results (where did the ME take place?)

Medication Errors – Results (nursing (psychiatric) home) 16/23 (70%)

Medication Errors – Results (the entire ME population) 18/53 (34%)

All enquiries to Giftlinjen (antipsychotics and antidepressants) 689/4406 (16%)

Medication Errors Conclusion Number of enquiries to GL about ME’s increases About 50% comes from nursing homes during summertime and the majority are related to the use of antipsychotic and antidepressant drugs The majority of ME’s are asymptomatic and only a few are categorised as life-threatening Half of the ME’s are single-dose incidences and half multiple-dose incidences Paracetamol is the major single agent leading to an ME

Methylphenidate (MPH) and its use as a drug of abuse Kim Dalhoff Giftlinjen (DPIC) & Department of Clinical Pharmacology Bispebjerg Hospital Denmark

Methylphenidate d,l-threo-methylphenidate (racemate) Approved for the treatment of ADHD and narcolepsy (1 DDD = 30 mg) MOA involves increasing dopamine via blockade of dopamin transporters MPH toxicity resembles the toxic effects of typical sympathomimetic drugs – including varying degrees of psychiatric and neurological effects Amphetamin

Methods Extraction of data from Giftlinjen = DPIC since (for 52 weeks) Search profile = methylphenidate or corresponding trade names registered in Denmark Categorization according to causes of MPH intake

Results

Conclusion Over a 4-year period, the number of MPH enquiries is increasing in Denmark (adjusted for ↑ total DPIC inquiries) The number of enquiries related to abuse users of MPH is increasing - relative to the total number of MPH enquires The abusers of MPH take larger doses and call later! The second largest group of abusers are in the age group 11 – 15 yrs A large number use other substances of abuse in addition to MPH

Perspectives A rapid development of a new and serious healthcare problem as a consequence of the increased use of a treatment of another healthcare problem! Healthcare Authorities need to know The treating psychiatrists need to know Our (DPIC) risk assessment may have to be adjusted in cases in which the patients has abused MPH Interventions are needed – more warnings, change in prescription patterns, early and more frequent monitoring of treated patients?